Health, Medicine & Biotechnology

Iran's health sector is best understood as a set of connected institutions rather than a single hospital service. The Ministry of Health and Medical Education combines responsibilities for health policy and regulation with medical training and service delivery. Medical universities consequently have roles extending beyond teaching and research into the organization of care. The Commonwealth Fund's country profile describes this institutional arrangement alongside a substantial public insurance system and private provision. s3

These functions answer different questions. A hospital or clinic provides care; an insurer helps finance specified services; a medical university trains professionals and may administer services; and a regulator establishes requirements. Institutional presence alone does not establish affordability, timely access, or quality. The distinction is especially important when reading national descriptions alongside evidence from particular provinces or facilities. s3s4

Community-based primary health care is a defining feature of Iran's system. UNICEF describes rural health houses staffed by community health workers known as behvarz, with health posts and comprehensive health centres forming other parts of the network. Their work includes maternal and child health and the prevention and management of communicable and noncommunicable diseases. The original equity objective was to narrow differences in access between rural and urban populations. s1

The WHO European Observatory's comparative account describes a layered organization: health houses connect with rural health centres, which link to higher levels of care. More specialized services are delivered through hospitals. This is a description of the intended organization of services and referral, not evidence that every patient follows a complete referral pathway or receives care without delay. s2

UNICEF's country brief reports a national infrastructure snapshot for 2022. The accompanying dataset preserves that reference year; the counts should not be presented as an inventory of facilities operating in October 2026. s1

Selected primary care and referral relationships

Arrows describe the rural service and referral sequence in the cited comparative account. They do not represent funding, appointment authority, or a guarantee of completed referrals.

The medical-services branch includes outpatient consultations, diagnostics, treatment, and hospital care. The Commonwealth Fund describes secondary and tertiary provision through general and specialized hospitals and clinics, with private providers particularly important in urban settings. Its account also identifies uneven geographic distribution of professionals. National capacity therefore needs to be considered alongside where staff and services are available. s3

Insurance is a separate part of this picture. Enrollment and financial protection are different measures: a person may hold coverage while still paying for services or medicines. The country profile describes public insurance organizations serving different population groups and continuing household payment burdens. Understanding access requires attention to covered benefits, patient contributions, and the practical availability of providers, rather than enrollment alone. s3

Electronic health records connect health technology with everyday service delivery. Research on Iran's Integrated Electronic Health System, known as SIB, examined users' and experts' experiences in health centres in Khuzestan. Participants described benefits including reduced paperwork, faster retrieval of information, and support for screening and evaluation. They also identified training, equipment, internet access, workload, confidentiality, and data accuracy as implementation concerns. s4

The study used qualitative interviews in selected centres. Its findings illuminate mechanisms and practical difficulties; they do not establish the frequency of those problems nationally. For readers exploring telemedicine, appointment systems, or health analytics, this is an essential distinction: installing a platform and demonstrating reliable, equitable clinical benefit are separate achievements. s4

Iran's biotechnology sector includes biological medicines as well as vaccines. A study published in the Indian Journal of Pharmaceutical Sciences documents domestic development of biosimilars and examines policies supporting their production. Biosimilars are follow-on biological medicines developed in relation to an existing biological product; assessing them involves more than matching the chemical formula of a conventional small-molecule generic. s5

The study describes capabilities involving recombinant proteins and monoclonal antibodies and discusses the roles of established institutes and newer manufacturers. Its market evidence is historical and cannot establish current production volumes or the availability of individual products. Domestic manufacturing capability, regulatory assessment, and access at the point of care must be evaluated separately. s5

Iran's statement to the World Health Assembly in 2024 also described vaccine-production ambitions. Such statements establish the government's account and intentions; they do not independently verify sustained production, international authorization, or delivery outcomes. s8

Public health connects this sector to prevention, nutrition, environmental conditions, and population needs. UNICEF identifies noncommunicable diseases and gaps in urban delivery among the pressures prompting reform. This extends the task beyond treating illness in hospitals to maintaining prevention and follow-up within communities. s1

Medicine supply adds another dimension. A mixed-methods study of sanctions and health in Iran reported patients' difficulties with availability and cost, while explicitly finding insufficient evidence for a compelling overall association between sanctions and population-health trends. Its qualitative findings and its more cautious quantitative conclusion should be read together. s6

More recent reporting makes historical system descriptions insufficient as a current service guarantee. Associated Press reporting in September 2026 described rising medicine prices, pharmacy-level supply difficulties, and disruption to import routes during war and blockade. These observations identify continuity risks; they do not constitute a comprehensive national facility assessment. Current operating capacity remains a research gap for this overview. s7